| Grant Title | Grantor | Amount | Award Date |
|---|
| Margaret Rosenfeld, MD, MPH | CF-ePRO: Electronic Self-and Parent-Reported Patient Outcomes in Cystic Fibrosis | NIH/NHLBI |
$$75,499 | Sept. 1, 2011 - Aug. 31, 2013 |
| Benjamin S. Wilfond, MD | Bioethics Consultation Standardization and Data-Sharing | NIH/NCRR |
$428,712 | Sept. 11, 2010 - May 31, 2011 |
| Margaret Rosenfeld, MD, MPH | Translational Research Center to Expedite Novel Therapies in Cystic Fibrosis | NIH/NIDDK |
$, $$200,642 | July 6, 2010 - May 31, 2015 |
| Margaret Rosenfeld, MD, MPH | PAS001 | Cystic Fibrosis Foundation Therapeutics Inc |
$$89,172.00 | Feb. 1, 2010 - Jan. 31, 2012 |
| Benjamin Wilfond, MD | Ethical Approaches to Genotype-Driven Research Recruitment | NHGRI |
$850,201.00 | Sept. 30, 2009 |
| Luke Hoffman, MD, PhD | Pseudomonas aeruginosa adaptation during early cystic fibrosis infection and treatment | NIH, National Heart, Blood, and Lung Institute |
$250,000.00 | Sept. 11, 2009 |
| Margaret Rosenfeld, MD, MPH | Genetic Disorders of Mucociliary Clearance | NIH (NCRR) |
$129,739.00 | Sept. 1, 2009 |
| Luke Hoffman, MD, PhD | Community-level physiologic profiling to identify new therapies for polymicrobial infectious diseases | Royalty Research Fund |
$30,622.00 | May 1, 2009 |
| Margaret Rosenfeld, MD, MPH | EPIC Observational Study | Cystic Fibrosis Foundation Therapeutics Inc |
$830,555.00 | April 1, 2009 |
| Benjamin Wilfond, MD | Parental Permission and the Adolescent Assent Process | NIH Clinical Center Department of Bioethics |
$29,000.00 | March 24, 2009 |
| Margaret Rosenfeld, MD, MPH | Parent Report of Signs of a Respiratory Exacerbation in Infants and Young Children with Cystic Fibrosis | NIH ITHS |
$10,000.00 | March 1, 2009 |
| Luke Hoffman, MD, PhD | Community-level physiologic profiling: A novel method to characterize polymicrobial infectious diseases | ITHS |
$10,000.00 | Feb. 1, 2009 |
| Margaret Rosenfeld, MD, MPH | Infant Study of Inhaled Saline | NIH/NHLBI |
$417,075.00 | Sept. 15, 2008 |
| Luke Hoffman, MD, PhD | The Impact of S. aureus normal and SCV forms in Cystic Fibrosis Lung Disease | The American Thoracic Society |
$50,000.00 | Jan. 1, 2008 |
| Luke Hoffman, MD, PhD | Bridge Funding to Develop Methods to Study Polymicrobial Community Interactions in Cystic Fibrosis Lung Disease | Cystic Fibrosis Foundation |
$75,000.00 | Jan. 1, 2008 |
| Luke Hoffman, MD, PhD | Alteration of Pseudomonas aeruginosa gene expression by sublethal cationic antibiotic concentrations | Cystic Fibrosis Foundation |
$85,000.00 | Jan. 1, 2008 |
| Benjamin S. Wilfond, MD | The Ethical and Policy Implications of Growth Attenuation in Children with Profound Developmental Disabilities | Greenwall Foundation-Bioethics Award Program |
$40,000 | Jan. 1, 2008 - Dec. 31, 2008 |
| Margaret Rosenfeld, MD, MPH | Infant Study of Inhaled Saline | Cystic Fibrosis Foundation |
$378,356.00 | Oct. 1, 2007 |
| Gregory Redding, MD | Bronchiectasis Observational Study in Alaska Native Children | NIH/NARCH III (Native American Research Centers for Health) |
$439,288.00 | Sept. 15, 2005 |
| Gregory Redding, MD | Pediatric Pulmonary Training Grant, Seattle, Washington | U.S. Department of Health and Human Services, Maternal and Child Health Bureau, HRSA |
$1,846,000.00 | July 1, 2005 |
| Margaret Rosenfeld, MD, MPH | Spirometry in Preschool CF Patients | Cystic Fibrosis Foundation |
$180,663.00 | Feb. 1, 2005 |